REATA PHARMACEUTICALS INC Notes Receivable, Fair Value Disclosure
REATA PHARMACEUTICALS INC had Notes Receivable, Fair Value Disclosure of $34.00 thousand as of 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Notes › Fair Value Disclosures
us-gaap:NotesReceivableFairValueDisclosure · last filed 2017-11-13
- 2017-09-30: Notes Receivable, Fair Value Disclosure $34.00K.
- 2017-06-30: Notes Receivable, Fair Value Disclosure $32.00K.
- 2017-03-31: Notes Receivable, Fair Value Disclosure $30.00K.
- 2016-12-31: Notes Receivable, Fair Value Disclosure $28.00K.
| Period end | Notes Receivable, Fair Value Disclosure |
|---|---|
| 2017-09-30 | $34.00K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $32.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $30.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $28.00K 10-Q · filed 2017-11-13 |
| 2016-09-30 | $166.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $156.00K 10-Q · filed 2016-08-11 |
| 2015-12-31 | $138.00K 10-K · filed 2017-03-03 |